Am­per­sand snags $50M as Flag­ship fo­cus­es ther­a­peu­tics on de­sired tar­gets on­ly 

The be­he­moth biotech cre­ator Flag­ship Pi­o­neer­ing is out with an­oth­er start­up aim­ing to achieve the crown jew­el of drug de­vel­op­ment: treat­ments that hit on­ly the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER